Clinical Trial Update: Measurement of PSMA Expression in Vivo in Recurrent Meningiomas by PET Imaging: a Preliminary Study to a Therapeutic Trial Using Radioligand Therapy (RLT) [NA]

View source ↗

Summary

Preliminary study using PSMA PET imaging to measure PSMA expression in recurrent meningiomas, aiming to support a planned radioligand therapy trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Meningioma | NA | Status: NOT_YET_RECRUITING